Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American College of Cardiology Scientific Sessions

Curr Atheroscler Rep. 2022 Aug;24(8):671-680. doi: 10.1007/s11883-022-01042-6. Epub 2022 May 28.


Purpose of review: Focused review highlighting select studies presented at the 2022 American College of Cardiology (ACC) Scientific Sessions.

Recent findings: Included studies assessed the impact of a low-sodium diet on heart failure outcomes (SODIUM-HF); outcomes of pregnant patients with chronic hypertension treated with antihypertensive therapies (CHAP); cardiovascular outcomes in patients with type 2 diabetes and renal impairment treated with sotagliflozin (SCORED); a safety and efficacy study investigating SLN360, a short interfering RNA targeting lipoprotein(a) (APOLLO); a supermarket and web-based intervention targeting nutrition for cardiovascular risk reduction (SuperWIN); a superiority trial comparing myocardial injury following very mild perioperative hypothermia versus aggressive warming after non-cardiac surgery (PROTECT); and 3-year efficacy outcomes of renal denervation on blood pressure reduction from the SPYRAL HTN-ON MED pilot study. Research presented at the 2022 ACC Scientific Sessions underscores the new potential and meaningful impact of cardiovascular disease prevention and management interventions.

Keywords: Cardiovascular prevention; DASH diet; Heart failure; Hypertension; Lipoprotein(a); Sotagliflozin.

Publication types

  • Review

MeSH terms

  • Cardiology*
  • Cardiovascular Diseases* / prevention & control
  • Diabetes Mellitus, Type 2* / complications
  • Humans
  • Kidney
  • Pilot Projects
  • United States